Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
ST. GALLEN, Switzerland & UNIONDALE, N.Y.--(BUSINESS WIRE)--Dec 10, 2021--
More from Virginia Business
Virginia Lawyers Weekly
Securities claims can't be based on puffery, boasting
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
022-2-247 -- Zeigler v. Eastman Chemical Company
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
Court clarifies 'statutory employees' exception
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
022-2-243 -- Capps v. Newmark Southern Region LLC
Virginia Business
•
Dec 5, 2022